Regeneron Pharmaceuticals, Inc. (REGN)
642.44
-7.32
(-1.13%)
USD |
NASDAQ |
May 21, 16:00
642.44
0.00 (0.00%)
After-Hours: 19:59
Regeneron Pharmaceuticals Research and Development Expense (TTM) : 5.526B for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Amgen, Inc. | 7.514B |
| AbbVie, Inc. | 9.501B |
| Biogen, Inc. | 1.607B |
| Eli Lilly & Co. | 14.11B |
| Merck & Co., Inc. | 21.57B |